HANSBERGER FOREIGN GROWTH FUND
                 (FORMERLY, CDC IXIS INTERNATIONAL EQUITY FUND)
                                  (THE "FUND")

SUPPLEMENT  DATED FEBRUARY 25, 2005 TO CDC NVEST EQUITY FUNDS CLASSES A, B AND C
AND CLASS Y PROSPECTUS  EACH DATED FEBRUARY 1, 2005, EACH AS MAY BE SUPPLEMENTED
FROM TIME TO TIME

Effective  immediately,   IXIS  Asset  Management   Distributors,   L.P.  ("IXIS
Distributors"), the distributor for Hansberger Foreign Growth Fund (the "Fund"),
will no longer accept new investments in the Fund. Effective March 9, 2005, IXIS
Distributors  will  no  longer  accept   additional   investments  from  current
shareholders of the Fund, including additional  investments through automatic or
systematic investment plans.

On February 22, 2005,  the Board of Trustees of Loomis Sayles Funds II, upon the
recommendation  of IXIS Asset  Management  Advisors,  L.P.  (the Adviser for the
Fund),  approved a plan to liquidate the Fund, such liquidation to take place on
or about  March  11,  2005  (the  "Liquidation  Date").  Any  shares of the Fund
outstanding on the Liquidation Date will be automatically redeemed on that date.
The proceeds of any such  redemption  will be the net asset value of such shares
after  charges,  dividend  distributions  required to eliminate  any  Fund-level
taxes, expenses and liabilities of the Fund have been paid or otherwise provided
for.  For  federal  income  tax  purposes,   the  automatic  redemption  on  the
Liquidation  Date will generally be treated like any other  redemption of shares
and may result in a gain or loss for federal income tax purposes.  Any gain will
result in short- or  long-term  capital  gains for  shareholders  who hold their
shares as a capital asset  depending on how long a  shareholder  has held his or
her Fund shares.  A shareholder  should  consult with his or her tax advisor for
more information on his or her own situation.

At any time prior to the Liquidation Date,  shareholders may redeem their shares
of the Fund pursuant to the procedures set forth in the Fund's  Prospectus under
"Fund  Services  - Selling  Shares."  Such  redemptions,  unlike  the  automatic
redemptions  upon  the  Liquidation  Date,  will be  subject  to any  applicable
contingent  deferred sales charges.  Shareholders may also exchange their shares
for shares of the same class of any other CDC Nvest Fund that offer that  class,
as described in the Prospectus  under "Fund Services - Exchanging  Shares." Such
an  exchange  will not  result in any  sales  charge.  For  federal  income  tax
purposes,  an  exchange  of Fund  shares for shares of another CDC Nvest Fund is
generally  treated  as a sale  on  which a gain or  loss  may be  recognized.  A
shareholder  should consult with his or her tax adviser for more  information on
his or her own situation.

Absent an instruction to the contrary  prior to the  Liquidation  Date, for Fund
shares  held in  individual  retirement  accounts  ("IRAs") or SIMPLE  IRAs,  in
custodial  accounts  under a SEP,  SARSEP,  or 403(b) plan,  or in certain other
retirement accounts, IXIS Distributors will exchange any shares remaining in the
Fund on the  Liquidation  Date into the CDC Nvest Cash  Management  Trust  Money
Market Series.



                                                                      SP250-0205